Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic LeukemiaJohn C. Byrd, Richard R. Furman, Thomas G. Diacovo et al.|New England Journal of Medicine|2015Cited by 890
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain–engineered monoclonal antibodyFarrukh T. Awan, John C. Byrd|Blood|2009Cited by 128
Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic LeukemiaCooper Quartermaine, Daniel Addison, Sanam Ghazi et al.|JACC CardioOncology|2023Cited by 107
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022William G. Wierda, Hema Sundar, Jeremy S. Abramson et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 84
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024William G. Wierda, Mary A. Dwyer, Jennifer R. Brown et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 83